Joana Vitallé
- Immunology top 5%
- Immune Cell Function and Interaction 17
- T-cell and B-cell Immunology 6
- Immune cells in cancer 5
- Mast cells and histamine 3
- IL-33, ST2, and ILC Pathways 2
- Oncology top 10%
- CAR-T cell therapy research 2
- Virology top 10%
- HIV Research and Treatment 6
-
- Urticaria and Related Conditions 3
- Co-authors
- Francisco BorregoOlatz ZenarruzabeitiaIñigo TerrénAne OrrantiaCristina EguizábalVenkateswara R. SimhadriItziar AstigarragaAgurtzane Bilbao
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Frontiers in Immunology (5 papers)Scientific Reports (3 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- SpainUnited StatesSweden
In The Last Decade
Joana Vitallé
21 papers receiving 773 citations
Peers
Comparison fields: 5 of 73
- Immunology 548
- Oncology 252
- Cancer Research 115
- Virology 33
- Immunology and Allergy 33
Countries citing papers authored by Joana Vitallé
This map shows the geographic impact of Joana Vitallé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joana Vitallé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joana Vitallé more than expected).
Fields of papers citing papers by Joana Vitallé
This network shows the impact of papers produced by Joana Vitallé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joana Vitallé. The network helps show where Joana Vitallé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joana Vitallé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 54 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 29 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 18 | |
| 13 | 2019 | 26 | |
| 14 | 2019 | 365 | |
| 15 | 2018 | 32 | |
| 16 | 2018 | 8 | |
| 17 | 2018 | 40 | |
| 18 | 2018 | 17 | |
| 19 | 2017 | 9 | |
| 20 | 2016 | 25 |
About Joana Vitallé
Joana Vitallé is a scholar working on Virology, Immunology and Biological Psychiatry, having authored 24 papers that have together received 778 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (17 papers), HIV Research and Treatment (6 papers), T-cell and B-cell Immunology (6 papers), Immune cells in cancer (5 papers), Urticaria and Related Conditions (3 papers), Mast cells and histamine (3 papers), CAR-T cell therapy research (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). The work is most often cited by research in Immunology (548 citations), Oncology (252 citations) and Cancer Research (115 citations). Joana Vitallé has collaborated with scholars based in Spain, United States and Sweden. Frequent co-authors include Francisco Borrego, Olatz Zenarruzabeitia, Iñigo Terrén, Ane Orrantia, Cristina Eguizábal, Venkateswara R. Simhadri, Itziar Astigarraga, Agurtzane Bilbao, Javier Martín‐González and Pedro Gamboa. Their work appears in journals such as Frontiers in Immunology, Scientific Reports, International Journal of Molecular Sciences, iScience and Seminars in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.